Update date
22 Apr 2026
C3is Inc. financial metrics
Period Q4 2025 · Filed 22 Apr 2026
Share Metrics
| Metric | Latest value | YoY relative change |
|---|---|---|
| Common Stock, Shares, Outstanding |
659,668
Period-end balance · 31 Dec 2025
|
+1767% |
| Common Stock, Value, Issued |
$6,597
Period-end balance · 31 Dec 2025
|
+1769% |
Supporting Metrics
These supporting metrics stay fully source-backed for deeper research. Scan the latest value and reported period first, then open a metric page when you need the full filing trail.
| Metric | Latest value | YoY relative change |
|---|---|---|
| Accrued Liabilities, Current |
$911,201
Period-end balance · 31 Dec 2025
|
-28% |
| Additional Paid in Capital |
$90,601,172
Period-end balance · 31 Dec 2025
|
+27% |
| Assets |
$98,486,630
Period-end balance · 31 Dec 2025
|
-2% |
| Assets, Current |
$20,838,709
Period-end balance · 31 Dec 2025
|
+28% |
| Cash and Cash Equivalents, at Carrying Value |
$616,640
Period-end balance · 31 Dec 2025
|
-87% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$616,640
Period-end balance · 31 Dec 2025
|
-87% |
| Common Stock, Par or Stated Value Per Share |
0.01
Period-end balance · 31 Dec 2025
|
0% |
| Common Stock, Shares Authorized |
2,000,000,000
Period-end balance · 31 Dec 2025
|
0% |
| Common Stock, Shares, Issued |
659,668
Period-end balance · 31 Dec 2025
|
+1767% |
| Inventory, Net |
$1,312,062
Period-end balance · 31 Dec 2025
|
+48% |
| Liabilities |
$3,387,016
Period-end balance · 31 Dec 2025
|
-88% |
| Liabilities and Equity |
$98,486,630
Period-end balance · 31 Dec 2025
|
-2% |
| Liabilities, Current |
$3,357,855
Period-end balance · 31 Dec 2025
|
-82% |
| Operating Lease, Liability, Current |
$24,751
Period-end balance · 31 Dec 2025
|
-14% |
| Other Assets, Current |
$282,992
Period-end balance · 31 Dec 2025
|
|
| Preferred Stock, Par or Stated Value Per Share |
0.01
Period-end balance · 31 Dec 2025
|
0% |
| Preferred Stock, Shares Authorized |
200,000,000
Period-end balance · 31 Dec 2025
|
0% |
| Property, Plant and Equipment, Gross |
$94,990,150
Period-end balance · 31 Dec 2025
|
0% |
| Property, Plant and Equipment, Net |
$77,647,921
Period-end balance · 31 Dec 2025
|
-7.7% |
| Retained Earnings (Accumulated Deficit) |
$4,485,845
Period-end balance · 31 Dec 2025
|
+1645% |
| Stockholders' Equity Attributable to Parent |
$95,099,614
Period-end balance · 31 Dec 2025
|
+33% |
Comparisons, sources and research notes
Sources and sharing
CISS - C3is Inc. Financial Facts
- Context
- Latest metrics period: Q4 2025
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open metric pages to inspect the reported history.
Tracking and update notes
Why revisit this company facts page
Company facts change as new 10-Q and 10-K filings update the latest reported period, headline values, and cross-company comparison context.
- Latest source-backed update
- Latest metrics period Q4 2025
- Why come back
- Use the next filing cycle to compare new facts against this baseline and then verify the detailed metric history.
- Current latest metrics period: Q4 2025.
- Most recent SEC facts end date on this page: 31 Dec 2025.
- Save this filer to return when the next filing-backed metric period changes the picture.
Freshness comes from the latest SEC company facts period available for this filer and the linked metric history pages.
Latest update
Latest update for CISS - C3is Inc.
Latest financial period: Q4 2025. Reopen this facts page to verify the newest reported period against the prior baseline.
Page type
Company facts
Latest period
Q4 2025
SEC-backed company facts were refreshed from filings filed on 22 Apr 2026.
Filing notes and source
Key facts
- CISS - C3is Inc. financial facts use SEC filings; any third-party reference is labeled separately.
- Latest metrics period on this page: Q4 2025.
- Headline metric summary will appear when SEC facts are available.
Change
- No metrics are currently available for comparison on this facts page.
- Changes will populate automatically as new 10-Q/10-K periods are processed.
Research use
- This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
- Metric cards link to SEC history; a third-party reference may use a different or unverified reporting period.
Evidence
Based on latest 10-Q/10-K
View source filing
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open company facts to inspect the reported metric history.
Valuation Snapshot
SEC-only DCF estimate using a normalized free cash flow base, cash, debt, and reported share count when available.
DCF value materially above price
Undervalued
Medium confidence
919094%
fair value gap
Fair value per share
$551.52
Market price
$0.0600
CISS - Local security
PEG ratio
0.0x
P/E 0.0x / growth 6.2%
Net Income CAGR (2Y)
Enterprise value
$192.44M
Equity value
$193.06M
DCF fair value scenarios
Bear
$411.60
- Growth
- 9%
- Discount
- 11%
- Terminal
- 2%
Gap 685895%
Base
$551.52
- Growth
- 12%
- Discount
- 10%
- Terminal
- 2.5%
Gap 919094%
Bull
$771.46
- Growth
- 15%
- Discount
- 9%
- Terminal
- 3%
Gap 1285666%
Base growth: Free Cash Flow CAGR (2Y).
Key valuation metrics
EV/Revenue
n/a
Local security market EV / SEC revenue
Market enterprise value is unavailable
EV/EBITDA
n/a
Local security market EV / SEC EBITDA
Market enterprise value is unavailable
P/E
0.0x
Local security market price / SEC EPS
P/S
0.0x
Local security market cap / SEC revenue
P/B
0.0x
Local security market cap / SEC equity
PEG
0.0x
P/E / Net Income CAGR
Core assumptions
- Projection
- 5 years
- FCF growth
- 4%
- Discount rate
- 10%
- Terminal growth
- 2.5%
SEC fact inputs
- DCF base FCF
- $9.51M
- Normalized SEC FCF average
- Reported FCF
- $3.84M
- Net income
- $10.47M
- EBITDA
- $7.87M
- Cash
- $616.6K
- Debt
- n/a
- Equity
- $95.1M
- Shares
- 350,055
Data confidence notes
- Dcf base free cash flow: dcf base starts from trailing sec free cash flow
- Dcf base free cash flow: trailing free cash flow is below recent annual free cash flow, so dcf uses a normalized sec average
- Debt missing: equity value treats debt as 0
- Dcf historical free cash flow growth is capped for scenario conservatism
Financial Quality Score
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
n/a
Insufficient Data Confidence low
Financial Health
Calculation methodology and other links
How we score
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
| Metric | Weight | V1 threshold |
|---|---|---|
| ROIC | 20 | 5% to 20% |
| ROE | 15 | 8% to 25% |
| ROA | 10 | 2% to 10% |
| Operating Margin | 5 | 5% to 25% |
| Current Ratio | 12 | 1.0x to 2.0x |
| Quick Ratio | 8 | 0.8x to 1.5x |
| Debt to Equity | 10 | 0.3x to 2.0x (lower is better) |
| Revenue YoY | 10 | -10% to +20% |
| Net Income YoY | 10 | -10% to +20% |
How Calculated (standard_v1)
Metrics are computed with a market-consensus convention designed for cross-portal comparability.
- Operating Income / Revenues using matching TTM or quarter periods; basis shown per metric
- Current Assets / Current Liabilities (latest instant quarter)
- (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
- Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
- TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
- TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
- TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
- Revenues YoY using available TTM or quarter comparison; basis shown per metric
- Net Income YoY using available TTM or quarter comparison; basis shown per metric
CIK / security context first